Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Clayton Associates
AddedFeb 15, 2024
UpdatedJun 28, 2026
Clayton Associates

Clayton Associates

Operating

Clayton Associates, L.L.C.: A U.S. venture capital firm providing early-stage and growth equity in healthcare sectors.

Location
Brentwood, TN, US
Founded
1996
Firm
Compare
Portfolio
Employees
Website

Clayton Associates, L.L.C. is a U.S.-based venture capital firm specializing in early-stage and growth equity investments within the healthcare sector, including healthcare services and healthcare technology companies. The firm typically participates in Series A and Series B funding rounds, with occasional involvement in seed, Series C, Series D, convertible notes, and debt financing rounds.

Notable portfolio companies include AdhereHealth, Clarus Care, JourneyPure, Kerafast, and NuScriptRx. The firm's investment philosophy centers on fostering innovation in healthcare by providing not only capital but also strategic support to its portfolio companies. Key decision-makers at Clayton Associates leverage their extensive industry experience to offer unique value-add services, enhancing the growth and success of the companies they invest in.

Clayton Associates - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments21
Current Portfolio Count9
Total Portfolio Exits2

Top Investment Stages

Series A7 (41.2%)
Series B4 (23.5%)
Series Unknown3 (17.6%)
Convertible Note2 (11.8%)
Angel1 (5.9%)

Stage Mix

Series A 41%Series B 24%Series Unknown 18%Convertible Note 12%Angel 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

StudioNow logo

StudioNow

MediQuire logo

MediQuire

Kerafast logo

Kerafast

LogoGarden logo

LogoGarden

JourneyPure logo

JourneyPure

Clarus Care logo

Clarus Care

NuScriptRx logo

NuScriptRx

Inova Payroll logo

Inova Payroll

ProviderTrust logo

ProviderTrust

AdhereHealth logo

AdhereHealth

Pathfinder Therapeutics logo

Pathfinder Therapeutics

CeloNova Biosciences logo

CeloNova Biosciences

Clayton Associates - Similar Investment Firms

Claytonia Capital logo

Claytonia Capital

Claremont Creek Ventures logo

Claremont Creek Ventures

claremontcreek.com

CHV Capital logo

CHV Capital

chvcapital.com

Catalysta Ventures logo

Catalysta Ventures

Intermountain Ventures logo

Intermountain Ventures

Alliance Healthcare Partners logo

Alliance Healthcare Partners

Healthcare Ventures logo

Healthcare Ventures

hcven.com

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Caduceus Capital Partners logo

Caduceus Capital Partners

caduceus.vc

Concord Health Partners logo

Concord Health Partners

concordhp.com

Assurant Ventures logo

Assurant Ventures

assurant.com

NCL Technology Ventures logo

NCL Technology Ventures

nclim.co.uk

Health Catalyst Capital logo

Health Catalyst Capital

Venture Investors logo

Venture Investors

Draper Associates logo

Draper Associates

draper.vc

Clayton Associates - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end